Determination of free and total insulin and C-peptide in insulin-treated diabetics.
about
Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humansRegulation by insulin of liver carbamoyl-phosphate synthase II (glutamine-hydrolysing)Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure.Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humansMuscle protein turnover and glucose uptake in acutely uremic rats. Effects of insulin and the duration of renal insufficiency.Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to ratsMetabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemiaFasting plasma leptin level is a surrogate measure of insulin sensitivity.Glucocorticoid induction of epinephrine synthesizing enzyme in rat skeletal muscle and insulin resistance.Insulin reciprocally regulates glucagon secretion in humansDifferent alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.Prevalence of insulin resistance in siblings of type 2 diabetics of north west punjabi population.Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.Direct muscarinic cholinergic inhibition of hepatic glucose production in humans.Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in manInfluence of hyperglycemia on insulin's in vivo effects in type II diabetesFamilial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epineReversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusionThe effects of anti-insulin antibodies and cross-reactivity with human recombinant insulin analogues in the E170 insulin immunometric assay.Whole foods and increased dietary fibre improve blood glucose control in diabetic childrenAdrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.Transplacental passage of insulin complexed to antibodyRole of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitusDynamic responses to leptin secretagogues in lean, obese, and massively obese men and womenInsulin action on heart and skeletal muscle glucose uptake in essential hypertensionAdaptation in brain glucose uptake following recurrent hypoglycemiaPretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study.Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia
P2860
Q24609701-4930DCE6-46C4-4BF8-8626-3A9570A69404Q28584266-CD09C0AF-38F9-4BBC-99EC-5317CA3C4752Q31136480-3EE43B9D-85BF-4623-9BD2-20C22F0DD25EQ33696446-F3545BCD-74E0-4142-AB0F-B053EB552558Q33822222-4F98E8A2-4EBC-4943-9606-33FDF0FEE569Q33822374-272DC379-B15C-470E-B10A-6DB9F0458EC9Q33822392-571EDB27-8209-41EB-8E68-D844E7A13DEAQ33892550-DD407DF5-E799-45EF-BE01-B3A500222629Q34032047-7017517C-8225-4081-B416-DED55BBCD39AQ34112697-ED3E92AA-8AFB-480F-BDDE-5490FC744664Q34135501-DE4EA650-D4D0-40E8-BB84-3E4AAC582A93Q34147396-138F19C9-2E51-46EA-8362-0F660C128AD5Q34152244-AC0AADB9-767C-4162-B6CB-AE3D4B8F136DQ34310570-A92922B5-FA36-46EB-99EC-7342844038BBQ34519321-59EE22E5-255C-4406-ADA2-6E578987E7B3Q34559150-9FFB0CAF-E6B0-4D11-B853-1C0D5BAC3E99Q34563673-571C155D-16EB-4B5C-AB62-56A5FE754242Q34602608-10B7996F-9286-499A-9797-798808C2438FQ34605059-F374EBC8-EFDF-40CE-B1B1-51FBDBE2C410Q34605349-1001D62B-40AB-4F58-9056-AEB16931D857Q34606880-CC468804-FCDE-4119-8D35-F42CF43E7D9CQ34609676-BED87A04-F465-4465-98CC-EB5A9779C605Q34629732-BE7F2C11-6ED9-469A-B2F9-1DF4F83FE684Q34996902-FCC0D04F-FBC2-4E61-A7F2-58B702FB5160Q35034188-6B60B77C-EAC2-4111-A7E0-4B6F5D72BD39Q35115885-FE06CDDE-D5C0-4AD8-A54E-C01DCD2A69CCQ35208934-39F5B883-7AAF-48BF-B265-58DFD7062571Q35409793-95CEB3AD-F3F9-4D88-A7F8-7B1FD48F9A8CQ35588279-10D934C3-FED4-4CB7-9AB8-6F515A91E13CQ35737743-43217545-210A-41AE-8314-1638A5057B6DQ35752974-103BFCDD-0357-400D-9305-935FB5EFE35FQ35782351-27134EF7-191E-4CBE-AA4C-983E1E331CE9Q35820541-F08B0754-3E1D-46E8-B07D-3BB500E535BCQ36617954-997AF8BA-9D08-4F0A-B242-216EFC8826D5Q36756571-EBA74072-C2A8-4F45-B8D3-8608E86D5B97Q36766235-90004591-503B-4622-B8EB-2D307911A644Q36945251-584D8234-2BB7-49FA-9574-FA083F047DDAQ37007413-007103E3-813E-4844-9E08-8D711D8A5BB0Q37023053-4998EEDB-428E-45E4-BDE9-A1AD883FFA6BQ37038219-D246918C-E27F-4513-AC5F-ED4CAD83645D
P2860
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh-hant
name
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@en
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@nl
type
label
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@en
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@nl
prefLabel
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@en
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@nl
P2093
P356
P1433
P1476
Determination of free and total insulin and C-peptide in insulin-treated diabetics.
@en
P2093
P356
10.2337/DIAB.26.1.22
P407
P577
1977-01-01T00:00:00Z